Starling Oncology, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $172.7M
Liabilities Breakdown FY2024
Total Liabilities: $169.1M
Asset Breakdown
Total Assets: $172.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $49.7M | 28.8% |
| Accounts Receivable | $48.3M | 28.0% |
| Inventory | $10.0M | 5.8% |
| Property, Plant & Equipment | $11.9M | 6.9% |
| Goodwill | $7.2M | 4.2% |
| Intangible Assets | $14.8M | 8.6% |
| Other Assets | $30.7M | 17.8% |
Liabilities Breakdown
Total Liabilities: $169.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $24.3M | 14.4% |
| Long-Term Debt | $93.1M | 55.1% |
| Other Liabilities | $51.7M | 30.6% |